Aceso Life Science Group (HKSE:00474) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00474 Aceso Life Science Group Ltd HKSE:00474
19 GF Score
Price HK$0.11
GF Value HK$0.08
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Aceso Life Science Group Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Aceso Life Science Group Valuation Rank Related Terms

HKSE:00474
19GF Score
Aceso Life Science Group Ltd HKSE:00474
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Aceso Life Science Group (HKSE:00474) Overvalued in 2026?

Based on GuruFocus' analysis, Aceso Life Science Group stock appears to be overvalued. The current stock price of HK$0.11 is trading 42.5% above its estimated GF Value™ of HK$0.08. GuruFocus considers Aceso Life Science Group to be Significantly Overvalued.

Key valuation signals for HKSE:00474:

  • Valuation Rank:
  • GF Value™: HK$0.08 vs. price of HK$0.11 (42.5% above fair value)
  • GF Score™: 19/100 with 8 warning signs

No single metric tells the full story. See the HKSE:00474 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aceso Life Science Group Business Description

Address 6 - 8 Harbour Road, Rooms 2501 - 2509, 25th Floor, Shui On Centre, Wanchai, Hong Kong, HKG
Aceso Life Science Group Ltd is an investment holding company. The group's operating segments include Money lending, Rental and sale of construction machinery and spare parts business, Provision of repair and maintenance and transportation service business, Provision of asset management, securities brokerage, commodities, futures, and other financial service business, Property leasing business, and Property development business. It derives key revenue from the rental and sale of construction machinery and spare parts. Geographically, the group has a business presence in Hong Kong, the UK, the PRC, Macau, and Cambodia.
19GF Score

Get the complete analysis for HKSE:00474

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.11
Price
HK$0.08
GF Value